English
Japanese
COVID Hot topics
-
WHO updates recommended COVID-19 treatments
21 April, 2022
Updated recommendations for adults at high risk of hospitalisation...COVID-19
-
First cases of XE subvariant detected
South Korea // 21 April, 2022
Other subvariants also found…COVID-19
-
First case of COVID-19 XE recombinant variant
Brazil // 20 April, 2022
First XE case in the country...COVID-19
-
Initiative to reduce COVID-19 hospital admissions
Rwanda // 19 April, 2022
COVID-19 booster doses can be taken at three months after ..COVID-19
-
Booster dose of Pfizer/BioNTech in children shows good response
United States // 16 April, 2022
Clinical trial data showed good immune response after booster dose in children ages 5 to 11....COVID-19
-
Valneva COVID-19 vaccine approved
United Kingdom // 15 April, 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Valneva vaccine for...COVID-19
-
Vaccine Update - Vaccinations for children and issuance of vaccine passport begins
Vietnam // 15 April, 2022
Health authorities begin vaccinating children aged five to 11 years...COVID-19
-
COVID-19 breath test authorised
United States // 15 April, 2022
The United States Food and Drug Administration (FDA) issued an emergency use authorisation (EUA) for a COVID-19 diagnostic test that uses breath...COVID-19
-
First case of COVID-19 XE recombinant variant
Japan // 14 April, 2022
First in the country...COVID-19
-
COVID-19 update for Africa, April
14 April, 2022
COVID-19 in AfricaCOVID-19
-
XE and other Omicron recombinant variants
Australia // Belgium // Denmark // Finland // Netherlands // United Kingdom // 14 April, 2022
More Omicron recombinants identified...COVID-19
-
WHO IHR Emergency Committee on COVID-19 11th meeting
14 April, 2022
The COVID-19 pandemic remains a Public Health Emergency of International Concern.....COVID-19, General Articles
-
Mixed and recombinant COVID-19 variants in NSW
Australia // 13 April, 2022
Delta/Omicron recombinant and XE variants reported.....COVID-19
-
Omicron BA.4 and BA.5 subvariants
Botswana // Denmark // Germany // South Africa // United Kingdom // 12 April, 2022
Two new Omicron subvariants, BA.4 and BA.5, have been reported by WHO and UK health authorities...COVID-19
-
Inflammation from COVID-19 may be the cause of loss of smell
United States // 12 April, 2022
SARS-CoV-2 virus not directly responsible…COVID-19
-
Omicron cases appear to be shorter in duration with reduced probability of hospitalisation than Delta cases, study
United Kingdom // 10 April, 2022
A study published in the Lancet...COVID-19
-
Fluvoxamine and reduced COVID-19 hospitalisation, study
09 April, 2022
A systematic review and meta-analysis published on JAMA Network...COVID-19
-
Risks of developing deep vein thrombosis, pulmonary embolism and bleeding after COVID-19, study
Sweden // 09 April, 2022
A study published in the BMJ...COVID-19
-
FDA no longer authorises use of sotrovimab
United States // 08 April, 2022
In any US state and territory...COVID-19
-
Protection by fourth dose of Pfizer vaccine, study
08 April, 2022
Rates of COVID-19 infection lowered...COVID-19
